MoonLake Immunotherapeutics ($MLTX)
Filing Information
| Accession Number | 0001213900-26-042629 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 10, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
87,795
Total Value
$1,663,934.55
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Class A ordinary shares, par value $0.0001 per share | โ | Apr 9, 2026 | Sale | 85,870 | $18.94 | $1,626,377.80 | 1,190,435 | Direct | โ | View Details | |
Chief Financial Officer | Class A ordinary shares, par value $0.0001 per share | โ | Apr 10, 2026 | Sale | 1,925 | $19.51 | $37,556.75 | 1,188,510 | Direct | โ | View Details |